AN3365|AN-3365|Epetraborole|antibiotic

AN3365|AN-3365|Epetraborole|antibiotic

AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics.

Product Name: AN3365(Epetraborole)|Cat No: DC9827|cas: 1234563-16-6|Other Names: AN 3365,AN-3365,GSK2251052,GSK 2251052,GSK-2251052

AN3365 is a novel boron-based, small-molecule product candidate that targets the bacterial enzyme leucyl tRNA synthetase. Preclinical studies suggest that AN3365 is a promising compound for the treatment of infections caused by a broad range of Gramnegative bacteria, including E. coli, K. pneumoniae, Citrobacter spp, S.marcescens, P.vulgaris, Providentia spp and Enterobacter spp. AN3365 has demonstrated a potent effect on strains harboring known resistance to widely-used antibiotics.

For the research and scientific use only, not for human use!